The most important financial indicators for the company Editura Medicart S.r.l. - Unique Identification Number 26233395:
sales in 2023 was
77.306
euro, registering a net profit of
34.681
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de editare a cartilor having the NACE code 5811.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 55.6%, from 49.835 euro in the year 2022, to 77.306 euro in 2023.
The Net Profit increased by 6.483 euro, from 28.283 euro in 2022, to 34.681 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Editura Medicart S.r.l. - CUI 26233395
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
0
0
0
0
0
0
0
0
0
14.699
Current Assets
250.011
270.474
239.838
318.781
353.665
385.510
228.744
255.019
381.683
415.875
Inventories
141.098
151.786
146.707
175.750
190.399
215.172
86.325
130.289
202.066
243.456
Receivables
83.305
82.800
88.663
128.192
125.107
124.137
113.304
111.405
163.511
160.388
Cash
25.607
35.888
4.469
14.839
38.159
46.201
29.116
13.325
16.106
12.031
Shareholders Funds
74.319
78.712
81.414
123.529
137.031
163.675
47.204
81.884
99.749
108.594
Social Capital
89
90
89
88
86
84
83
81
81
81
Debts
185.505
201.656
158.424
195.252
217.034
222.226
181.925
173.511
283.777
327.698
Income in Advance
360
363
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"5811 - 5811"
CAEN Financial Year
5811
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
415.875 euro in 2023 which includes Inventories of
243.456 euro, Receivables of
160.388 euro and cash availability of
12.031 euro.
The company's Equity was valued at
108.594 euro, while total Liabilities amounted to
327.698 euro.
Equity increased by 9.148 euro, from 99.749 euro in 2022, to 108.594 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Editura Medicart S.r.l.